| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1086 |
| Trial ID | CTRI/2019/09/021329 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Modified T cells for the treatment of relapsed/ refractory B-cell Acute Lymphoblastic Leukemia -2nd Stage of a Multi-stage Project |
| Year | 2019 |
| Country | India |
| Company sponsor | Tata Educational and Development Fund a Division of Tata Trusts Inc |
| Cohort 1 | |||||||
|
|||||||